Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MESH: Multiple Sclerosis / drug therapy"'
Autor:
Chadia Ed‐driouch, Florent Chéneau, Françoise Simon, Guillaume Pasquier, Benoit Combès, Anne Kerbrat, Emmanuelle Le Page, Sophie Limou, Nicolas Vince, David‐Axel Laplaud, Franck Mars, Cédric Dumas, Gilles Edan, Pierre‐Antoine Gourraud
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, 2022, 9 (12), pp.1863-1873. ⟨10.1002/acn3.51649⟩
Annals of Clinical and Translational Neurology, 2022, 9 (12), pp.1863-1873. ⟨10.1002/acn3.51649⟩
International audience; Objective: Multiple sclerosis (MS) is a multifactorial disease with increasingly complicated management. Our objective is to use on-demand computational power to address the challenges of dynamically managing MS.Methods: A pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0344e51453a7dc5208d4f2246e8cc8ac
https://pubmed.ncbi.nlm.nih.gov/36412095
https://pubmed.ncbi.nlm.nih.gov/36412095
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
Autor:
Fissolo, Nicolás, Pignolet, Beatrice, Rio, Jordi, Vermersch, Patrick, Ruet, Aurélie, deSèze, Jerome, Labauge, Pierre, Vukusic, Sandra, Papeix, Caroline, Martinez-Almoyna, Laurent, Tourbah, Ayman, Clavelou, Pierre, Moreau, Thibault, Pelletier, Jean, Lebrun-Frenay, Christine, Bourre, Bertrand, Defer, Gilles, Montalban, Xavier, Brassat, David, Comabella, Manuel, Universitat Autònoma de Barcelona
Publikováno v:
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
ObjectivesThe study aimed to assess the potential for serum neurofilament light chain (NFL) levels to predict the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab (NTZ)-treated patients with multiple sclerosis (MS) and to discr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7e556e5e596930706054f15c466294
https://doi.org/10.1212/nxi.0000000000001003
https://doi.org/10.1212/nxi.0000000000001003